Assistant Professor Akira Sobue and Professor Koji Yamanaka of the Research Institute of Environmental Medicine and Graduate School of Medicine at Nagoya University in Japan have reported a potential ...
An F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. patent details new cannabinoid CB2 receptor modulators reported to be useful for the treatment of neuropathic pain, asthma, osteoporosis, ...
If there aren’t enough reasons already, add more leafy greens to your diet. Research has shown that leafy greens rich with the terpene beta-caryophyllene activate the CB2 receptor in mice models. Beta ...
Genescience Pharmaceuticals Co. Ltd. has described cannabinoid CB2 receptor agonists reported to be useful for the treatment of arthritis, systemic lupus erythematosus, inflammatory bowel disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results